<DOC>
	<DOCNO>NCT01433640</DOCNO>
	<brief_summary>This pilot study evaluate 2D contrast-enhanced mammography image 3D ( tomosynthesis ) contrast-enhanced image contrast enhance MRI woman great 95 % probability breast cancer ( BIRADS 5 ) confirm breast cancer ( BIRADS 6 ) .This study use design additional study .</brief_summary>
	<brief_title>Dual-energy Contrast-enhanced ( 2D 3D Mammography Versus Contrast-enhanced MRI ) - A Pilot Study</brief_title>
	<detailed_description />
	<criteria>Subject female race ethnicity . Subject least 25 year old Subject contrast enhance breast MRI +/ 31 day enrollment interval treatment procedure two study Subject BIRADS 6 BIRADS 5 cancer determine radiologist &gt; 50 % biopsied cancer mass must remain following biopsy OR A calcification must least 2cm maximum dimension prior biopsy least 1cm maximum dimension follow biopsy Subject unable unwilling undergo inform consent Subject breast implant breast image Subject pregnant Subject breast feeding lactate Subject know allergy gadolinium contrast agent . Subject contraindication MRI . Subject suspect risk complication contrast agent . Subject document renal insufficiency , Subject require renal dialysis . Subject prior reaction iodinate contrast . Subject prior episode anaphylactic reaction substance . Subject take metformin ( Glucophage ) within 48 hour study procedure . Subject multiple allergy and/or severe asthma regularly treat medication ( prescription and/or overthecounter ) .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>image multi-modalities</keyword>
	<keyword>visualize cancer lesion</keyword>
	<keyword>highly suspicious lesion</keyword>
</DOC>